SCHEMBL16815134

SCHEMBL16815134

CC[C@@H]1C[C@@H](CC(=O)O)CCO1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A12 P48065 5/20 0.35
SLC6A11 P48066 5/20 0.35
SLC6A13 Q9NSD5 5/20 0.35
SLC6A1 P30531 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRB2 P47870 2/20 0.35
GABRA1 P14867 1/20 0.35
GABRR1 P24046 1/20 0.35
GABRA4 P48169 1/20 0.35
ALDH1A1 P00352 3/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
EPHX1 P07099 1/20 0.32
HPGD P15428 1/20 0.31
ANPEP P15144 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4414140 1.00 SLC6A12 (0.35) SLC6A12SLC6A11SLC6A13SLC6A1GABRA5
SCHEMBL15700782 0.86 EPHX1 (0.38) SLC6A12SLC6A11SLC6A13SLC6A1GABRA5
SCHEMBL16815135 0.80 MIF (0.36) ALDH1A1POLBCYP1A2HPGD
SCHEMBL15136255 0.78 EPHX1 (0.40) EPHX1
SCHEMBL10211021 0.78 SLC6A12 (0.37) SLC6A12SLC6A11SLC6A13SLC6A1GABRA5
SCHEMBL16815159 0.78 SLC6A12 (0.37) SLC6A12SLC6A11SLC6A13SLC6A1GABRA5
SCHEMBL17294479 0.78 SLC6A12 (0.37) SLC6A12SLC6A11SLC6A13SLC6A1GABRA5
SCHEMBL15700783 0.76 SLC6A12 (0.38) SLC6A12SLC6A11SLC6A13SLC6A1GABRA5
SCHEMBL5066828 0.75 INPP5A (0.46) EPHX1
SCHEMBL3375533 0.74 SLC6A12 (0.42) SLC6A12SLC6A11SLC6A13SLC6A1GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015088817-A1 4,4'-BIPHENYLDIYL-BIS-(1 H-IMIDAZOLYL) DERIVATIVES AS HEPATITIS HCV INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-06-18 WO disclosed